Showing results (91-100 of 277) with videos related to

Sort By:
Pageof 28
Journal of Drugs in Dermatology : JDD|December 31, 2008
Verrucous linear (segmental) psoriasis of the right leg responding to radiation therapyFiona Larsen, Alan Menter, Clay J Cockerell, et al.
Journal of the American Academy of Dermatology|November 13, 2007
Alefacept revisited: Our 3-year clinical experience in 200 patients with chronic plaque psoriasisAmy Perlmutter, Jennifer Cather, Billy Franks, et al.
Expert Opinion on Emerging Drugs|November 27, 2013
Emerging topical treatments for psoriasisDario N Kivelevitch, Katherine R Hebeler, Mahir Patel, et al.
Clinical Pharmacology and Therapeutics|September 30, 2017
Anti-IL-23 and Anti-IL-17 Biologic Agents for the Treatment of Immune-Mediated Inflammatory ConditionsJillian Frieder, Dario Kivelevitch, Isabel Haugh, et al.
Dermatology and Therapy|June 7, 2022
Narrative Review of the Emerging Therapeutic Role of Brodalumab in Difficult-to-Treat PsoriasisAlan Menter, Tina Bhutani, Benjamin Ehst, et al.
Journal of Drugs in Dermatology : JDD|April 7, 2022
Long-Term Skin Clearance With Brodalumab in Patients With Psoriasis and Inadequate Response to Prior BiologicsMark Lebwohl, Alan Menter, Edward Lain, et al.
Journal of Drugs in Dermatology : JDD|May 3, 2011
Infliximab treatment for psoriasis in 120 patients on therapy for a minimum of one year: a reviewQurat Ul Ain Kamili, Andrew Miner, Asli Hapa, et al.
Journal of the American Academy of Dermatology|October 16, 2013
Research gaps in psoriasis: opportunities for future studiesCaitriona Ryan, Neil J Korman, Joel M Gelfand, et al.
Expert Review of Clinical Immunology|November 8, 2017
The impact of biologic agents on health-related quality of life outcomes in patients with psoriasisJillian Frieder, Dario Kivelevitch, Connie Tran Fiore, et al.
Pageof 28